| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
50,958 |
48,827 |
$4.51M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,723 |
6,617 |
$868K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,470 |
5,375 |
$280K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,904 |
1,879 |
$161K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
621 |
618 |
$90K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,787 |
3,695 |
$89K |
| 99050 |
|
3,799 |
3,753 |
$59K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,507 |
1,485 |
$47K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
419 |
408 |
$39K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
288 |
288 |
$30K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
956 |
939 |
$29K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
941 |
924 |
$28K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
169 |
169 |
$23K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
150 |
150 |
$23K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
149 |
149 |
$22K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
147 |
147 |
$21K |
| 84703 |
|
2,787 |
2,717 |
$19K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
122 |
122 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,112 |
1,101 |
$14K |
| 87430 |
|
1,111 |
1,101 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
70 |
69 |
$10K |
| 87210 |
|
2,054 |
1,990 |
$10K |
| 86703 |
|
769 |
766 |
$9K |
| 90686 |
|
407 |
407 |
$9K |
| 86780 |
|
605 |
605 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
129 |
127 |
$7K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
222 |
197 |
$6K |
| 90651 |
|
63 |
63 |
$6K |
| 99051 |
|
1,488 |
1,475 |
$5K |
| 81003 |
|
2,464 |
2,406 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
540 |
540 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
454 |
453 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
31 |
31 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
388 |
388 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
422 |
420 |
$3K |
| 80061 |
Lipid panel |
543 |
541 |
$3K |
| 81025 |
|
425 |
420 |
$3K |
| 97802 |
|
62 |
62 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
323 |
321 |
$2K |
| 90670 |
|
73 |
73 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
15 |
$2K |
| 80053 |
Comprehensive metabolic panel |
256 |
256 |
$2K |
| 86803 |
|
149 |
149 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
125 |
125 |
$2K |
| 81001 |
|
598 |
590 |
$2K |
| 0134A |
|
38 |
38 |
$2K |
| 92015 |
Determination of refractive state |
132 |
132 |
$2K |
| 90715 |
|
95 |
95 |
$2K |
| 90633 |
|
50 |
50 |
$1K |
| 82274 |
|
78 |
78 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
30 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
401 |
396 |
$1K |
| 0054A |
|
22 |
22 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
166 |
165 |
$1K |
| 85027 |
|
173 |
172 |
$1K |
| 90734 |
|
55 |
55 |
$974.88 |
| 0004A |
|
18 |
18 |
$825.84 |
| 99173 |
|
14 |
14 |
$317.42 |
| 86706 |
|
31 |
31 |
$303.80 |
| 82043 |
|
28 |
27 |
$145.32 |
| 82570 |
|
27 |
26 |
$125.49 |
| 90707 |
|
12 |
12 |
$109.83 |
| 80076 |
|
12 |
12 |
$86.32 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
16 |
$22.31 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
62 |
62 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
26 |
26 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
141 |
140 |
$0.00 |
| 91313 |
|
35 |
35 |
$0.00 |
| 91300 |
|
56 |
56 |
$0.00 |
| 90648 |
|
13 |
13 |
$0.00 |
| 91305 |
|
30 |
30 |
$0.00 |
| 91307 |
|
14 |
14 |
$0.00 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$0.00 |
| 90680 |
|
16 |
16 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.00 |